4.6 Review

The microbiome and critical illness

Journal

LANCET RESPIRATORY MEDICINE
Volume 4, Issue 1, Pages 59-72

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S2213-2600(15)00427-0

Keywords

-

Funding

  1. National Institutes for Health via Michigan Institute for Clinical & Health Research [UL1TR000433]
  2. Host Microbiome Initiative of the University of Michigan
  3. University of Michigan Center for Integrative Research in Critical Care
  4. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER
  5. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL130641, T32HL007749] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The central role of the microbiome in critical illness is supported by a half century of experimental and clinical study. The physiological effects of critical illness and the clinical interventions of intensive care substantially alter the microbiome. In turn, the microbiome predicts patients' susceptibility to disease, and manipulation of the microbiome has prevented or modulated critical illness in animal models and clinical trials. This Review surveys the microbial ecology of critically ill patients, presents the facts and unanswered questions surrounding gut-derived sepsis, and explores the radically altered ecosystem of the injured alveolus. The revolution in culture-independent microbiology has provided the tools needed to target the microbiome rationally for the prevention and treatment of critical illness, holding great promise to improve the acute and chronic outcomes of the critically ill.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available